Pharmacokinetic Characteristics of Ibandronate and Tolerability of DP-R206 (150 mg Ibandronate/24,000 IU Vitamin D3) Compared to the Ibandronate (150 mg) Monotherapy in Healthy Adults
Pharmacokinetic Characteristics of Ibandronate and Tolerability of DP-R206 (150 mg Ibandronate/24,000 IU Vitamin D3) Compared to the Ibandronate (150 mg) Monotherapy in Healthy Adults
Title
Pharmacokinetic Characteristics of Ibandronate and Tolerability of DP-R206 (150 mg Ibandronate/24,000 IU Vitamin D3) Compared to the Ibandronate (150 mg) Monotherapy in Healthy Adults
Author
Hee Youn Choi, Mi Jo Kim, Yo Han Kim, Yook-Hwan Noh, Jae-won Lee, Tae-won Lee, Min-Gul Kim, Kyun-Seop Bae
Year
2014
Journal
Transl Clin Pharmacol
Details
2014 Jun;22(1):22-29
DOI
10.12793/tcp.2014.22.1.22
첨부파일
첨부파일이(가) 없습니다.
다음글
Beneficial Effects of Korean Traditional Diets in Hypertensive and Type 2 Diabetic Patients
김민걸
2021-09-18 23:34:38.0
이전글
Comparison of the Pharmacokinetics, Safety, and Tolerability of Vitamin D3 in DP-R206 (150-mg Ibandronate/24,000-IU Vitamin D3 Tablet) and as Monotherapy (24,000 IU) in Healthy Male Korean Adults